IDH1 and glioblastoma: All samples had molecular features of glioblastoma, including TERT promoter mutation (C228T), lack of IDH1 R132H mutation (confirmed by immunohistochemistry in all cases, and additionally by sequencing in two cases), and gain of chromosome 7 (Additional file 18: Table S1).